PYXS Stock Analysis: Buy, Sell, or Hold?
PYXS - Pyxis Oncology, Inc. Common Stock
$2.76
-0.31 (-10.26%)
▼
5d:
-8.47%
30d:
+54.78%
90d:
+88.7%
HOLD
MODERATE Confidence
Analysis Updated: Jul 8, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When PYXS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PYXS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PYXS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PYXS is currently trading at $2.75, which is considered extended relative to its 30-day fair value range of $1.66 to $2.62.
Technical Outlook: Technically, PYXS is in a uptrend. The price is approaching resistance at $1.88. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 10.3% recently.
Market Sentiment: PYXS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.75 (+119.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PYXS is in a uptrend. The price is approaching resistance at $1.88. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 10.3% recently.
Market Sentiment: PYXS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.75 (+119.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.66 -
$2.62
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price extended above range (+5.2% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-10.3%)
- BULLISH: Trading 119.9% below Wall St target ($6.75)
- CAUTION: 5-day price weakness (-8.5%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.66 -
$2.62
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.60
Resistance Level
$1.88
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.57
Wall Street Target
$6.75
(+119.9%)
Share & Embed Analysis
Last updated: July 08, 2026 2:30 PM ET
Data refreshes hourly during market hours. Next update: 3:30 PM
Data refreshes hourly during market hours. Next update: 3:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PYXS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$435 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 59 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 57 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 61 BUY |
